Active substance
Results for the substance bictegravir emtricitabine tenofovir
2 results
About this active substance
The combination of bictegravir, emtricitabine, and tenofovir is an antiretroviral treatment used for managing human immunodeficiency virus (HIV) infection. It combines three medications into a single daily tablet, simplifying the treatment regimen for patients. Bictegravir is an integrase inhibitor, while emtricitabine and tenofovir are nucleoside reverse transcriptase inhibitors, which prevent the virus from replicating.
This combination is indicated for adult and adolescent patients aged 12 years and older who are treatment-naïve or have a controlled viral load. The medication is well-tolerated by most patients, and regular administration can maintain undetectable viral levels, preventing disease progression and reducing the risk of transmission.
Common side effects include nausea, diarrhea, headache, and fatigue. In rare cases, more severe adverse effects such as kidney or liver dysfunction may occur. It is important for patients to undergo regular check-ups to monitor treatment safety.
The combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions and ensure treatment efficacy.
This combination is indicated for adult and adolescent patients aged 12 years and older who are treatment-naïve or have a controlled viral load. The medication is well-tolerated by most patients, and regular administration can maintain undetectable viral levels, preventing disease progression and reducing the risk of transmission.
Common side effects include nausea, diarrhea, headache, and fatigue. In rare cases, more severe adverse effects such as kidney or liver dysfunction may occur. It is important for patients to undergo regular check-ups to monitor treatment safety.
The combination is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions and ensure treatment efficacy.